Approvals/TGA/Flucelvax Quad Quadrivalent influenza vaccine (surface antigen inactivated) suspension for injection pre-filled syringe with attached needle - 2025 season

Approved

STANDARD

Flucelvax Quad Quadrivalent influenza vaccine (surface antigen inactivated) suspension for injection pre-filled syringe with attached needle - 2025 season

Seqirus Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: 1d0a312e2485df85
Company: Seqirus Pty Ltd
Type: Standard

Approval Details

Approval Id: 1d0a312e2485df85
Product Name: Flucelvax Quad Quadrivalent influenza vaccine (surface antigen inactivated) suspension for injection pre-filled syringe with attached needle - 2025 season
Artg Id: 341450
Artg Name: Flucelvax Quad Quadrivalent influenza vaccine (surface antigen inactivated) suspension for injection pre-filled syringe with attached needle
Sponsor: Seqirus Pty Ltd
Company Detail Path: /organization/seqirus-pty-ltd
Artg Date: 2020-09-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/704de3522e2e921c68a4d65dac4ce4ab.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8bee507a4570e3aa087018a6ef78aa45.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1d0a312e2485df85

Type

Standard

Back to TGA Approvals